InnoCan Pharma Corporation
INNO
Classement en actions
#33929
InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to... InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems that integrate cannabidiol (CBD) with other pharmaceutical compounds. Its operations and development efforts span across the United States, Poland, France, and various international markets. The company actively pursues research and development into treatments for conditions such as COVID-19, leveraging CBD delivered via exosomes and liposomes. InnoCan's product line features a range of CBD-infused topical items, including eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Beyond R&D, the corporation is also involved in the marketing and distribution of its proprietary CBD-enhanced pharmaceutical and cosmetic offerings. Established in 2018, InnoCan Pharma Corporation maintains its principal office in Calgary, Canada.
Prix de l'action
$1.39
Dernière synchronisation: 2026-10-15
Capitalisation boursière
$6.27M
Changement (1 jour)
0.00%
Changement (1 an)
-88.85%
Pays
CA
Échange InnoCan Pharma Corporation (INNO)
Catégorie
Healthcare
Capitalisation boursière de InnoCan Pharma Corporation(INNO)
Capitalisation boursière: $6.27M
En October 2026, InnoCan Pharma Corporation a une capitalisation boursière de $6.27M. Cela fait de InnoCan Pharma Corporation la 33929th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de InnoCan Pharma Corporation du 2020 au 2026
INNO par rapport au top 5 des plus populaires stocks
